Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
A CBC with differential can raise suspicion of leukemia or other cancers by revealing abnormal white blood cell counts, blast cells, anemia, or low platelets, but it cannot confirm a diagnosis on its own. Definitive answers require follow-up testing such as a peripheral blood smear, flow cytometry, bone marrow biopsy, or imaging, and some cancers produce a completely normal CBC. There are several important details and exceptions to consider, including which specific results tend to prompt urgent evaluation, all explained below. Because abnormal counts can also stem from infection, inflammation, medications, or nutrient deficiencies, understanding your full symptom picture matters before assuming the worst. Taking a free, instant, online symptom check can help you connect your lab findings to your symptoms and clarify whether you should seek prompt medical attention or monitor and retest.
Last reviewed for medical accuracy: 09/14/2026
A CBC with differential is one of the most common blood tests ordered by doctors. It measures overall blood health and breaks down the types of white blood cells (WBCs) you have. Many people wonder whether abnormalities on this test can point to leukemia or other cancers. Here’s a straightforward look at what a CBC with differential can—and can’t—do.
A CBC (complete blood count) measures:
Adding a differential breaks down your WBCs into specific types:
By giving both overall counts and relative percentages, a CBC with differential offers a detailed snapshot of your blood’s cellular makeup.
Physicians rely on this test to:
Because blood cancers like leukemia directly affect WBC counts and their development, a CBC with differential is often part of an initial work-up when leukemia is suspected.
Leukemia is a cancer of the blood-forming tissues, causing abnormal white blood cells to multiply. On a CBC with differential, doctors look for:
For example:
When these patterns emerge, they raise a red flag—but are not by themselves a cancer diagnosis.
While a CBC with differential can point toward a blood cancer, it can’t establish one. Reasons include:
To confirm leukemia or another hematologic cancer, doctors usually order:
These additional tests provide the detail needed for a firm diagnosis and help guide treatment plans.
A CBC with differential is not designed to find most solid tumors (lung, breast, colon, etc.). However, it may occasionally:
Still, normal results do not rule out solid tumors. Likewise, abnormal results usually lead to more targeted testing (imaging scans, biopsies) rather than a direct cancer diagnosis.
Most mild variations in blood counts have benign causes. You might consider further evaluation if you have:
If any of these accompany abnormal blood counts, it’s wise to follow up promptly with a healthcare provider.
Repeat the CBC with differential
Labs can vary. A repeat test confirms if an abnormality persists.
Peripheral smear review
A pathologist examines blood cells under a microscope for blasts or other unusual cells.
Referral to a hematologist/oncologist
Specialists will guide additional tests (bone marrow biopsy, cytogenetics).
Further imaging or organ-specific tests
For suspected solid tumors, you may need ultrasounds, CT scans or MRI.
If you’re experiencing concerning signs—or you simply want more clarity—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you organize your symptoms before talking to your doctor.
Remember:
A CBC with differential is often the first step if leukemia or another blood cancer is suspected. It provides valuable clues but isn’t definitive. If your counts are out of the ordinary—or if you have symptoms like unexplained fatigue, bruising or fevers—talk to a doctor right away. Prompt follow-up testing can make a critical difference in diagnosis and treatment.
Speak to a doctor about any serious or life-threatening concerns. Early evaluation and personalized guidance are essential for the best outcome.
(References)
* WALLERSTEIN RO, AGGELER PM. ACUTE HEMOLYTIC ANEMIA. Am J Med. 1964 Jul;37:92-104. doi: 10.1016/0002-9343(64)90214-1. PMID: 14181152.
* Anand H, Bakhshi S, Saxena R. Transient leukemia. Indian J Pathol Microbiol. 2009 Apr-Jun;52(2):257-9. doi: 10.4103/0377-4929.48938. PMID: 19332933.
* George TI. Malignant or benign leukocytosis. Hematology Am Soc Hematol Educ Program. 2012;2012:475-84. doi: 10.1182/asheducation-2012.1.475. PMID: 23233622.
* Giammarco S, Chiusolo P, Piccirillo N, Di Giovanni A, Metafuni E, Laurenti L, Sica S, Pagano L. Hyperleukocytosis and leukostasis: management of a medical emergency. Expert Rev Hematol. 2017 Feb;10(2):147-154. doi: 10.1080/17474086.2017.1270754. Epub 2016 Dec 26. PMID: 27967252.
* Kawamoto K, Miyoshi H, Yanagida E, Yoshida N, Kiyasu J, Kozai Y, Morikita T, Kato T, Suzushima H, Tamura S, Muta T, Kato K, Eto T, Seki R, Nagafuji K, Sone H, Takizawa J, Seto M, Ohshima K. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified. Eur J Haematol. 2017 May;98(5):459-466. doi: 10.1111/ejh.12856. Epub 2017 Mar 3. PMID: 28129454.
* Singh N, Singh Lubana S, Dabrowski L, Sidhu G. Leukostasis in Chronic Lymphocytic Leukemia. Am J Case Rep. 2020 Jul 3;21:e924798. doi: 10.12659/AJCR.924798. Epub 2020 Jul 3. PMID: 32616708; PMCID: PMC7360358.
* Kakaje A, Alhalabi MM, Ghareeb A, Karam B, Mansour B, Zahra B, Hamdan O. Interactions of Consanguinity and Number of Siblings with Childhood Acute Lymphoblastic Leukemia. Biomed Res Int. 2020;2020:7919310. doi: 10.1155/2020/7919310. Epub 2020 Dec 8. PMID: 33490255; PMCID: PMC7787732.
* Helenius M, Vaitkeviciene G, Abrahamsson J, Jonsson ÓG, Lund B, Harila-Saari A, Vettenranta K, Mikkel S, Stanulla M, Lopez-Lopez E, Waanders E, Madsen HO, Marquart HV, Modvig S, Gupta R, Schmiegelow K, Nielsen RL. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype-genotype study. Pediatr Blood Cancer. 2022 Jun;69(6):e29582. doi: 10.1002/pbc.29582. Epub 2022 Mar 22. PMID: 35316565.
* Zhang L, Liu J, Qin X, Liu W. Platelet-Acute Leukemia Interactions. Clin Chim Acta. 2022 Nov 1;536:29-38. doi: 10.1016/j.cca.2022.09.015. Epub 2022 Sep 16. PMID: 36122665.
* Tefferi A, Gangat N, Loscocco GG, Guglielmelli P, Szuber N, Pardanani A, Orazi A, Barbui T, Vannucchi AM. Essential Thrombocythemia: A Review. JAMA. 2025 Feb 25;333(8):701-714. doi: 10.1001/jama.2024.25349. PMID: 39869325.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.